Biofrontera AG: First quarter conference call to be held on May 12, 2021
03 May 2021 - 11:40PM
Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the
“Company”), an international biopharmaceutical company, will be
releasing its
financial results for the first quarter 2021 on
Tuesday, May 11, 2021.
Conference calls for shareholders and interested
investors will be held on Wednesday, May 12, 2021, at the following
times:
In German, May 12, 2021 at 10:00 am CEST (4:00
am EST)Dial-in number Germany: +49 69201744220Conference code:
60386865#
In English, May 12, 2021 at 2:00 pm CEST (8:00
am EST)Dial-in number USA: +1 8774230830Dial-in number UK: +44
2030092470Conference code: 52497289#
Please dial in 10 minutes ahead of time to
ensure a timely start of the conference
call.-End-
Biofrontera AGPamela Keck, Head of Investor
Relationsir@biofrontera.com+49-214-87632-0
About Biofrontera: Biofrontera
AG is a biopharmaceutical company specializing in the development
and sale of dermatological drugs and medical cosmetics.
The Germany-based company, with over 150
employees worldwide, develops and markets innovative products for
the care, protection and treatment of the skin. The company’s lead
product is the combination of Ameluz®, a topical prescription drug,
and medical device BF-RhodoLED® for the photodynamic therapy of
certain superficial skin cancers and their precursors. Ameluz® has
been marketed in the EU since 2012 and in the United States since
May 2016. In addition, the company markets the prescription
medication Xepi® for the treatment of impetigo in the United
States. In the EU, the company also sells the dermocosmetics series
Belixos®, which offers specialized care for damaged or diseased
skin.
Biofrontera is the first German founder-led
pharmaceutical company to receive a centralized European and a US
approval for a drug developed in-house. The Biofrontera Group was
founded in 1997 by the current CEO Prof. Dr. Hermann Lübbert and is
listed on the Frankfurt Stock Exchange (Prime Standard) and on the
US NASDAQ.www.biofrontera.com.
Biofrontera (NASDAQ:BFRA)
Historical Stock Chart
From Apr 2024 to May 2024
Biofrontera (NASDAQ:BFRA)
Historical Stock Chart
From May 2023 to May 2024